By Marleen Kaesebier (Reuters) -Switzerland's Galderma raised its full-year guidance on Thursday after third-quarter sales beat expectations despite pressure from U.S. tariffs, sending shares in the skincare company up around 7%. Third-quarter net sales came in at $1.29 billion compared with the$1.24 billion provided in a company-compiled consensus. Galderma, which listed in March 2024, now expects full-year net sales to increase by between 17% and 17.7% year-on-year at constant currency, up from 12% t ...